Table 2.
Sero-evidence of exposure to infectious disease agents in free-ranging Iberian lynx
| Sierra Morena (%) | Doñana NP (%) | Total (%) | |
|---|---|---|---|
| Toxoplasma gondii | 11.7 (2/17) | 61.0 (19/31) | 44.0 (21/48) |
| Feline herpesvirus | 6.2 (1/16) | 13.8 (4/29) | 11.1 (5/45) |
| Feline calicivirus | 6.2 (1/16) | 3.6 (1/28) | 4.5 (2/44) |
| Feline parvovirus | 6.2 (1/16) | 0 (0/21) | 2.6 (1/37) |
| Feline coronavirus | 0 (0/16) | 0 (0/21) | 0 (0/37) |
| Feline leukaemia virus | 0 (0/17) | 0 (0/21) | 0 (0/38) |
| Feline immunodeficiency virus | 0 (0/17) | 0 (0/21) | 0 (0/38) |
| Canine distemper virus | 0 (0/16) | 0 (0/21) | 0 (0/37) |
Prevalence in percent (positive/sampled)